Phase I/II Study of Split-dose TPF-Induction Chemotherapy Before Surgery of Oropharyngeal and Cavity of the Mouth Cancer.
Phase of Trial: Phase I/II
Latest Information Update: 11 May 2017
At a glance
- Drugs Cisplatin (Primary) ; Docetaxel (Primary) ; Fluorouracil (Primary)
- Indications Oropharyngeal cancer
- Focus Therapeutic Use
- Acronyms TISOC-1
- 02 Mar 2016 Status changed from active, no longer recruiting to completed, as reported by European Clinical Trials Database record.
- 05 Oct 2013 Status changed from recruiting to suspended as reported by European Clinical Trials Database.
- 02 Jun 2012 Other source identified and integrated: european Clinical Trials Database record EudraCT2009-011902-41.